Location, location, location: Beneficial effects of autologous fat transplantation

Scientific Reports

Volumn 1, Issue , 2011, Pages

  Satoor, Sarang N ^a   Puranik, Amrutesh S ^a,b   Kumar, Sandeep ^a   Williams, Michael D ^f   Ghale, Mallikarjun ^c   Rahalkar, Anand ^c   Karandikar, Mahesh S ^d   Shouche, Yogesh ^a   Patole, Milind ^a   Bhonde, Ramesh ^a,g   Yajnik, Chittaranjan S ^e   Hardikar, Anandwardhan A ^a,f  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b UNIVERSITY OF PUNE   (India)

^c Sahyadri Speciality Hospital Pune   (India)

^d HOSPITAL AND RESEARCH CENTRE   (India)

^e KEM HOSPITAL   (India)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g Manipal Academy of Higher Education   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; AUTOTRANSPLANTATION; BODY COMPOSITION; FEMALE; GENETICS; INTRAABDOMINAL FAT; METABOLISM; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSPLANTATION; WISTAR RAT;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; FEMALE; INTRA-ABDOMINAL FAT; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84860181012     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00081     Document Type: Article

References (47)

1. Alvehus M, B. J., SjöströmM, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) 18, 879-883. (2010).
2. Santosa, S. & Jensen, M. D. Why are we shaped differently, and why does it matter? Am J Physiol Endocrinol Metab 295, E531-535 (2008).
3. Tran, T. T., Yamamoto, Y., Gesta, S. & Kahn, C. R. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7, 410-420 (2008). (Pubitemid 351598027)
4. Banerji, M. A., Faridi, N., Atluri, R., Chaiken, R. L. & Lebovitz, H. E. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84, 137-144 (1999). (Pubitemid 29036692)
5. Hutley, L. & Prins, J. B. Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci 330, 280-289 (2005). (Pubitemid 41831898)
6. Scherer, P. E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537-1545 (2006). (Pubitemid 44324105)
7. Frayn, K. N. Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201-1210 (2002).
8. Snijder, M. B. et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 48, 301-308 (2005). (Pubitemid 40543303)
9. Umegaki, H., Haimoto, H., Ishikawa, J. & Kario, K. Visceral fat contribution of insulin resistance in elderly people. J Am Geriatr Soc 56, 1373-1375 (2008).
10. Cefalu, W. T. et al. Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 44, 954-959 (1995).
11. Anan, F. et al. Visceral fat accumulation is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients. Eur J Clin Invest 39, 368-374 (2009).
12. Anjana, M. et al. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care 27, 2948-2953 (2004). (Pubitemid 39565064)
13. Gastaldelli, A. et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 87, 5098-5103 (2002). (Pubitemid 35316351)
14. Matsuzawa, Y., Nakamura, T., Shimomura, I. & Kotani, K. Visceral fat accumulation and cardiovascular disease. Obes Res 3, 645S-647S (1995).
15. Mahabadi, A. A. et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30, 850-856 (2009).
16. Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E. & Klein, S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56, 1010-1013 (2007). (Pubitemid 46525079)
17. Zhang, H., Chen, X., Aravindakshan, J. & Sairam, M. R. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance. Endocrinology 148, 5667-5679 (2007). (Pubitemid 350146141)
18. Hayes, L. et al. Do obese but metabolically normal women differ in intraabdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC Public Health 10, 723.
19. Misra, A. et al. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 5, 93-99 (1997). (Pubitemid 127702753)
20. Snijder, M. B. et al. Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes Res 11, 104-111 (2003). (Pubitemid 41137545)
21. Miyazaki, Y. et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87, 2784-2791 (2002). (Pubitemid 34655345)
22. Kim, J. Y. et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117, 2621-2637 (2007).
23. Kim, H. J. et al. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model. Metabolism 56, 676-685 (2007). (Pubitemid 46574731)
24. Gavrilova, O. et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105, 271-278 (2000). (Pubitemid 30094446)
25. Gesta, S. et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci USA 103, 6676-6681 (2006).
26. Abumrad, N. N., Cherrington, A. D., Williams, P. E., Lacy, W. W. & Rabin, D. Absorption and disposition of a glucose load in the conscious dog. Am J Physiol 242, E398-406 (1982). (Pubitemid 12050348)
27. Fabbrini, E. et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 139, 448-455.
28. Montoya, T., Monereo, S., Olivar, J., Iglesias, P. & Diaz, P. Effects of orlistat on visceral fat after liposuction. Dermatol Surg 35, 469-474 (2009).
29. Culhane, J. C. & Cole, P. A. LSD1 and the chemistry of histone demethylation. Curr Opin Chem Biol 11, 561-568 (2007). (Pubitemid 47588999)
30. Tran, T. T. & Kahn, C. R. Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol 6, 195-213.
31. Tonna, S., El-Osta, A., Cooper, M. E. & Tikellis, C. Metabolic memory and diabetic nephropathy: potential role for epigeneticmechanisms. Nat Rev Nephrol 6, 332-341.
32. Brasacchio, D. et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58, 1229-1236 (2009).
33. El-Osta, A. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205, 2409-2417 (2008).
34. Bouchard, L. et al. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care 33, 2436-2441.
35. Yang, B. T. et al. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia 54, 360-367.
36. Ferrer, J. Glucose as a mitogenic hormone. Cell Metab 13, 357-358.
37. Porat, S. et al. Control of Pancreatic beta Cell Regeneration by Glucose Metabolism. Cell Metab 13, 440-449.
38. Metzger, E. et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437, 436-439 (2005). (Pubitemid 41613508)
39. Tsukada, Y. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811-816 (2006). (Pubitemid 43255695)
40. Wissmann, M. et al. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 9, 347-353 (2007).
41. Shi, Y. J. et al. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 19, 857-864 (2005).
42. Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 (2004). (Pubitemid 40037608)
43. Joglekar, M. V., Wei, C. & Hardikar, A. A. Quantitative estimation of multiple miRNAs andmRNAs from a single cell. Cold Spring Harb Protoc 2010, pdb prot5478.
44. Hauser, C., Schuettengruber, B., Bartl, S., Lagger, G. & Seiser, C. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol Cell Biol 22, 7820-7830 (2002). (Pubitemid 35217293)
45. Xu, C. R. et al. Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science 332, 963-966.
46. Ayala, J. E., Bracy, D. P., McGuinness, O. P. & Wasserman, D. H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55, 390-397 (2006). (Pubitemid 43343268)
47. Ayala, J. E. et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech 3, 525-534.